profits of Bt126.54mn, shares buyback of Bt101.80mn, and the interim dividend payment of Bt262.59mn. MB % MB % MB % Current assets 1,398.47 39.7% 1,230.40 35.9% -168.07 -12.0% Non-current assets 2,121.70

Other Non-current Financial Assets in accordance with the Financial Reporting Standard TFRS 9, Financial Instruments.  Liabilities increased by 62.60 million Bahts, from Deferred Tax liabilities which

beyond.  Reflecting current economic conditions, listed companies’ performances on the stock exchange and the index have significantly decreased. Nevertheless, there is a positive trend in corporate

As a result of the current situation, business operators have to self-adjust in response to technological disruption, the changing environment, and investors’ changing behaviors in order to

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

account from the delayed project Baht (56.85) million. • Property, plant and equipment decreased Baht (42.09) million due to depreciation. • Other non-current assets decreased by Baht (16.50) million

31, 2019, total assets of GFPT Group equal to THB 18,820.10 million including THB 5,713.54 million (30.36% of total assets) in current assets, THB 9,038.06 million (48.02% of total assets) in property

see the improvement of DE and Current ratio. However, the Balance Sheet restructuring is subject to the coming EGM which will be held on 30 August 2017. Apart from the improvement of Balance Sheet, the